BRAF mutation predicts survival after immunotherapy across multiple cancer types
Cancer Treatment and Research Communications · 2026 · 47 · 101215
DOI: 10.1016/j.ctarc.2026.101215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Shaojun Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, The Second People's Hospital of Quzhou, China. Electronic address: zoushaojun2000@163.com. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Neoplasms, Mutation, Immunotherapy. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Oncology, The Second People's Hospital of Quzhou, China. Electronic address: zoushaojun2000@163.com.
- Center for Basic Research (Key Laboratory of Cancer and Intervention, China National Ministry of Education), the Second Affiliated Hosptital, Zhejiang University School of Medicine, Hangzhou, China; Center for Medical R…
- Department of Medical Oncology, Zhejiang University School of Medicine, Second Affiliated Hospital, China. Electronic address: caiwen@zju.edu.cn.
Förderung
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Zhou, S., Ge, W., & Cai, W. (2026). BRAF mutation predicts survival after immunotherapy across multiple cancer types. Cancer Treatment and Research Communications, 47, 101215. https://doi.org/10.1016/j.ctarc.2026.101215
Vancouver
Zhou S, Ge W, Cai W. BRAF mutation predicts survival after immunotherapy across multiple cancer types. Cancer Treatment and Research Communications. 2026;47:101215. doi:10.1016/j.ctarc.2026.101215
BibTeX
@article{Zhou2026,
author = {Zhou, Shaojun and Ge, Weiting and Cai, Wen},
title = {BRAF mutation predicts survival after immunotherapy across multiple cancer types},
journal = {Cancer Treatment and Research Communications},
year = {2026},
volume = {47},
pages = {101215},
doi = {10.1016/j.ctarc.2026.101215}
}
EUVIMED